iOnctura

iOnctura is a biotech company in Geneva, Switzerland, founded in 2017. It has raised $85.5M across 1 round, most recently an $85.5M Series B in June 2024.

Home • iOnctura

Headquarters
Geneva
Employees
11–50
Founded
2017
Business Model
B2B
Total Funding
$85.5M
Last Round
$85.5M Series BJun 2024
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

Giving every cancer sufferer hope, iOnctura works every day to deliver treatments that have low toxicity and are gentle on the body, yet powerful in disrupting and inhibiting tumors. Its mission is to develop high impact, low disruption therapies that extend healthspan for patients by interrogating first-in-class mechanisms that disrupt the dynamic interplay at the heart of the tumor-stroma-immune interface.

Summary

It lists 11–50 employees. It has raised $85.5M in total across 1 round, most recently a $85.5M Series B round in Jun 2024. Investors include Syncona Partners.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series BSeries BJun 2024
$85.5M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

iOnctura on Indexed.vc
<a href="https://indexed.vc/companies/ionctura"><img src="https://indexed.vc/api/badge/company/ionctura" alt="iOnctura on Indexed.vc" width="260" height="76" /></a>